We are live on ! Find out more
AC

Aristeia Capital Portfolio holdings

AUM $4.82B
1-Year Est. Return 24.94%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+24.94%
3 Year Est. Return
+78.83%
5 Year Est. Return
+102.49%
10 Year Est. Return
+757.46%
AUM
$5B
AUM Growth
-$757M
Cap. Flow
-$1.42B
Cap. Flow %
-28.35%
Top 10 Hldgs %
30.23%
Holding
745
New
44
Increased
171
Reduced
34
Closed
217

Top Buys

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$43.4M
2
FWAC
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
+$21.8M
3
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$20.8M
4
JUGG
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
+$18.6M
5
VLAT
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
+$16.8M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$118M
2
OXY.WS icon
Occidental Petroleum Corp Warrants
OXY.WS
+$54.4M
3
CPUH
Compute Health Acquisition Corp.
CPUH
+$53M
4
SCOA
ScION Tech Growth I Class A Ordinary Shares
SCOA
+$41.9M
5
ASZ
Austerlitz Acquisition Corporation II
ASZ
+$38.4M

Sector Composition

Rank Sector Weight
1 Financials 48.69%
2 Communication Services 12.48%
3 Industrials 6.3%
4 Technology 3.81%
5 Energy 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFIVW
351
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$39.7K ﹤0.01%
530,147
-205,700
-28% -$9.83K
JWSM.WS
352
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$38.6K ﹤0.01%
561,895
– –
GRRRW
353
Gorilla Technology Group Warrant
GRRRW
$1.61M
$38.6K ﹤0.01%
199,255
+2,555
+1% +$723
BIOTW
354
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$37.4K ﹤0.01%
601,133
– –
FLFVR
355
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
$36.5K ﹤0.01%
450,000
– –
CXAIW icon
356
CXApp Inc Warrant
CXAIW
$957K
$36.2K ﹤0.01%
723,268
– –
SLAMW
357
DELISTED
Slam Corp. warrant
SLAMW
$35.5K ﹤0.01%
474,005
– –
COCHW icon
358
Envoy Medical Warrant
COCHW
$425K
$35K ﹤0.01%
890,642
– –
TBCPW
359
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$34.7K ﹤0.01%
442,260
– –
DNZ.WS
360
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$34.1K ﹤0.01%
612,409
– –
BLEUR
361
DELISTED
bleuacacia ltd Rights
BLEUR
$34K ﹤0.01%
400,000
– –
ATEK.WS
362
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$33.8K ﹤0.01%
750,000
– –
LGVCW
363
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$30.9K ﹤0.01%
375,000
– –
MACAW
364
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$29.8K ﹤0.01%
242,174
– –
ROCLW
365
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$29.7K ﹤0.01%
250,000
– –
PIIIW icon
366
P3 Health Partners Inc Warrant
PIIIW
$130K
$29.1K ﹤0.01%
182,091
-20,582
-10% -$10.7K
COOLW
367
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$27.8K ﹤0.01%
793,865
– –
RMGCW
368
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$27.2K ﹤0.01%
680,154
– –
PRLHW
369
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$27K ﹤0.01%
399,839
– –
ICNC.WS
370
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
$26.8K ﹤0.01%
196,500
-3,500
-2% -$254
PEGRW
371
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$26.7K ﹤0.01%
618,750
– –
HERAW
372
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$26.3K ﹤0.01%
957,014
– –
HWELW
373
DELISTED
Healthwell Acquisition Corp. I Warrant
HWELW
$26.3K ﹤0.01%
500,000
– –
TRTL.WS
374
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$24.9K ﹤0.01%
149,450
– –
CLDI.WS
375
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$24.8K ﹤0.01%
495,000
– –
13 14
15
16 17

Similar funds

TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
WAM
WT Asset Management Hong Kong $4.77B AUM 334.05% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Aristeia Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Aristeia Capital held 745 positions worth $5B, down 13% from $5.75B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Aristeia Capital withdrew a net $1.42B in Q4 2022, closing 217 positions and reducing 34 holdings. Its most notable exit was Marathon Petroleum, an estimated $118M position sold in full.

By sector, the portfolio is most concentrated in Financials at 49% of assets, down from 55% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Aristeia Capital opened a new position in Ross Acquisition Corp II worth $13.2M.

  • Aristeia Capital's largest Q4 2022 buy was Ross Acquisition Corp II: 1,308,217 shares worth $13.2M.
  • Aristeia Capital added most to Liberty Broadband Class C in Q4 2022, an estimated $43.4M increase.
  • Aristeia Capital's biggest Q4 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $54.4M.
  • Aristeia Capital fully exited Marathon Petroleum in Q4 2022, selling an estimated $118M.
  • Aristeia Capital's ten largest holdings make up 30% of its $5B portfolio in Q4 2022.
  • Aristeia Capital opened 44 new positions and closed 217 in Q4 2022.
  • Aristeia Capital's portfolio value fell 13% quarter-over-quarter to $5B.

Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.